CYSTIC FIBROSIS IN THE LIGHT OF CONTEMPORARY MEDICAL-GENETIC ADVANCES (A CLINICAL CASE STUDY) DOI Creative Commons

Дмитрий Евгеньевич Николенко,

O. K. Prylutskyi,

B. М. Fylenko

et al.

Bulletin of Problems Biology and Medicine, Journal Year: 2024, Volume and Issue: 1(4), P. 600 - 600

Published: Jan. 1, 2024

Language: Английский

Challenges to Optimizing Nutrition in Children With Cystic Fibrosis DOI
Charles B. Chen,

Jill A Granneman,

Subhash Yadav

et al.

Current Gastroenterology Reports, Journal Year: 2025, Volume and Issue: 27(1)

Published: March 7, 2025

Language: Английский

Citations

0
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health DOI Creative Commons
Elena K. Schneider‐Futschik, Yimin Zhu, Danni Li

et al.

Progress in Retinal and Eye Research, Journal Year: 2024, Volume and Issue: 103, P. 101299 - 101299

Published: Sept. 6, 2024

Language: Английский

Citations

2
Effect of Modulator Therapies on Nutritional Risk Index in Adults with Cystic Fibrosis: A Prospective Cohort Study DOI Open Access
Nadir Yalçın, Esen Deniz Akman, Oğuz Karcıoğlu

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(12), P. 1811 - 1811

Published: June 8, 2024

Background: Modulator therapies improve weight and body mass index (BMI) in cystic fibrosis (CF) patients. We aimed to compare the nutritional risk (NRI) adult CF patients receiving modulator (MT) or only non-modulator (conventional) (non-MT). Methods: A single-center prospective cohort study was conducted between June December 2023. The NRI based on gain albumin calculated at beginning end of a 12-week period both groups. This design pragmatic, since it individual patient access MT for 12 weeks. Results: In total, 107 were included [mean (SD) age: 23.85 (4.98) years, 54.7% male, 46.7% MT]. group, mean (kg) (g/dL) increased significantly [changes: +3.09 (2.74) +0.17 (0.37); p < 0.001]. non-MT decreased −0.99 (1.73) −0.12 (0.30); Compared baseline group higher [100.65 (11.80) vs. 104.10 (10.10); = 0.044]. At weeks, than [104.18 (10.40) 102.58 (12.39); 0.145]. category improved 22 (44%), worsened 3 (6%) (p 0.001). 2 (3.5%), 10 (17.5%) Conclusions: is first reporting positive effect NRIs, albumin. Personalized nutrition routine follow-up adults with recommended prior initiation.

Language: Английский

Citations

1
Special Issue: “Recent Advances in Ion Channels and Ion Channelopathies” DOI Open Access
Deanne H. Hryciw

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(7), P. 3598 - 3598

Published: March 22, 2024

The aim of this special issue was to showcase recent advanced in understanding ion channel function and dysfunction associated with disease [...]

Language: Английский

Citations

1
Cross-cultural adaptation and validation of the CFAbd-Score for gastrointestinal symptoms in patients with cystic fibrosis DOI Creative Commons
Flavia N. Souza, Elizete Aparecida Lomazi,

Carlos Zagoya

et al.

Jornal de Pediatria, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 1, 2024

Translating and cross-culturally adapting the CFAbd-Score, Cystic Fibrosis (CF) Abdominal Score, to use in Brazilian spoken Portuguese. The CFAbd-Score is a questionnaire for assessing CF-related abdominal symptoms their influence on quality of life (QoL). It comprises 28 questions five domains: pain, bowel movements, eating appetite, gastroesophageal reflux symptoms, impact gastrointestinal (GI) QoL.

Language: Английский

Citations

0
CYSTIC FIBROSIS IN THE LIGHT OF CONTEMPORARY MEDICAL-GENETIC ADVANCES (A CLINICAL CASE STUDY) DOI Creative Commons

Дмитрий Евгеньевич Николенко,

O. K. Prylutskyi,

B. М. Fylenko

et al.

Bulletin of Problems Biology and Medicine, Journal Year: 2024, Volume and Issue: 1(4), P. 600 - 600

Published: Jan. 1, 2024

Language: Английский

Citations

0